Jim Simons Horizon Therapeutics Public LTD CO Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $1.52 Million - $1.78 Million	-15,400 Reduced 0.45%	3,433,349 $397 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $7.74 Million - $9.02 Million	80,300 Added 2.38%	3,448,749 $355 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $182 Million - $192 Million	1,693,400 Added 101.1%	3,368,449 $368 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $7.09 Million - $12.9 Million	113,583 Added 7.27%	1,675,049 $191 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $10.5 Million - $15.1 Million	-178,800 Reduced 10.27%	1,561,466 $96.6 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $22.7 Million - $33.2 Million	-285,500 Reduced 14.09%	1,740,266 $139 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $21.7 Million - $27.6 Million	-251,300 Reduced 11.04%	2,025,766 $213 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $96 Million - $117 Million	-974,397 Reduced 29.97%	2,277,066 $245 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $90.6 Million - $109 Million	-986,200 Reduced 23.27%	3,251,463 $356 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $83.9 Million - $93.3 Million	-972,300 Reduced 18.66%	4,237,663 $397 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $114 Million - $152 Million	-1,589,000 Reduced 23.37%	5,209,963 $480 Million
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $133 Million - $167 Million	-1,981,912 Reduced 22.57%	6,798,963 $497 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $84.6 Million - $122 Million	-1,532,000 Reduced 14.86%	8,780,875 $682 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $9.39 Million - $17.7 Million	-310,800 Reduced 2.93%	10,312,875 $573 Million
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $13 Million - $20.2 Million	523,000 Added 5.18%	10,623,675 $315 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $19.1 Million - $27.5 Million	750,100 Added 8.02%	10,100,675 $366 Million
Q3 2019 Nov 13, 2019	BUY	$23.0 - $27.97 $13.7 Million - $16.7 Million	596,300 Added 6.81%	9,350,575 $255 Million
Q2 2019 Aug 12, 2019	BUY	$22.81 - $28.48 $200 Million - $249 Million	8,754,275 New	8,754,275 $211 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account